The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Hydrophobic Imbalance in the Cytoplasmic Domain of Phospholamban Is a Determinant for Lethal Dilated Cardiomyopathy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As previously pointed out [71], the DCM variants of PLN display higher hydrophobicity of domain Ia.”
From Pathological mutations in the phospholamban cytoplasmic region affect its topology and dynamics modulating the extent of SERCA inhibition (2024) · cites this paper as [71]
In the citing paper
“Interestingly, PLNR9C and PLNR9L displayed similar spectral changes relative to PLN, with significantly larger tilt angles and an unassigned envelope of peaks in the center of the wheel patterns, suggesting that the hydrophobic substitutions of R9 influence their TM orientation and activity as previously observed [71].”
From Pathological mutations in the phospholamban cytoplasmic region affect its topology and dynamics modulating the extent of SERCA inhibition (2024) · cites this paper as [71]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alterations of Sarcoplasmic Reticulum Proteins in Failing Human Dilated Cardiomyopathy
Meyer, M., Schillinger, W., Pieske, B., Holubarsch, C., Heilmann, C., Posival, H., Kuwajima, G., Mikoshiba, K., Just, H., & Hasenfuss, G. (1995) · Circulation · doi:10.1161/01.cir.92.4.778 · Cited by 535
Research works printed but not linked: 54
- Dellefave, 2010, The genetics of dilated cardiomyopathy, Curr. Opin. Cardiol., 25, 198, 10.1097/HCO.0b013e328337ba52 · DOI · Paper page
- Kirchberber, 1975, Phospholamban. A regulatory protein of the cardiac sarcoplasmic reticulum, Recent Adv. Stud. Cardiac Struct. Metab., 5, 103
- Simmerman, 1986, Sequence Analysis of Phospholamban. Identification of Phosphorylation Sites and Two Major Structural Domains, J. Biol. Chem., 261, 13333, 10.1016/S0021-9258(18)69309-3 · doi:10.1016/s0021-9258(18)69309-3
- MacLennan, 2003, Phospholamban. A crucial regulator of cardiac contractility, Nat. Rev. Mol. Cell Biol., 4, 566, 10.1038/nrm1151 · DOI · Paper page
- Hasenfuss, 1994, Relation between myocardial function and expression of sarcoplasmic reticulum Ca2+-ATPase in failing and nonfailing human myocardium, Circ. Res., 75, 434, 10.1161/01.RES.75.3.434 · DOI · Paper page
- Minamisawa, 2003, Mutation of the phospholamban promoter associated with hypertrophic cardiomyopathy, Biochem. Biophys. Res. Commun., 304, 1, 10.1016/S0006-291X(03)00526-6 · DOI
- Haghighi, 2008, A human phospholamban promoter polymorphism in dilated cardiomyopathy alters transcriptional regulation by glucocorticoids, Hum. Mutat., 29, 640, 10.1002/humu.20692 · DOI
- Haghighi, 2003, Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human, J. Clin. Invest., 111, 869, 10.1172/JCI17892 · DOI · Paper page
- Landstrom, 2011, PLN-encoded phospholamban mutation in a large cohort of hypertrophic cardiomyopathy cases. Summary of the literature and implications for genetic testing, Am. Heart J., 161, 165, 10.1016/j.ahj.2010.08.001 · DOI
- Schmitt, 2003, Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban, Science, 299, 1410, 10.1126/science.1081578 · DOI · Paper page
- DeWitt, 2006, Phospholamban R14 deletion results in late-onset, mild, hereditary dilated cardiomyopathy, J. Am. Coll. Cardiol., 48, 1396, 10.1016/j.jacc.2006.07.016 · DOI
- Haghighi, 2006, A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy, Proc. Natl. Acad. Sci. U.S.A., 103, 1388, 10.1073/pnas.0510519103 · DOI · Paper page
- Posch, 2009, Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes, Heart Rhythm, 6, 480, 10.1016/j.hrthm.2009.01.016 · doi:10.1016/j.hrthm.2009.01.016
- Medeiros, 2011, Mutations in the human phospholamban gene in patients with heart failure, Am. Heart J., 162, 1088, 10.1016/j.ahj.2011.07.028 · DOI
- Rapti, 2011, Targeted gene therapy for the treatment of heart failure, Can. J. Cardiol., 27, 265, 10.1016/j.cjca.2011.02.005 · DOI
- Ha, 2011, Lethal Arg9Cys phospholamban mutation hinders Ca2+-ATPase regulation and phosphorylation by protein kinase A, Proc. Natl. Acad. Sci. U.S.A., 108, 2735, 10.1073/pnas.1013987108 · DOI
- Douglas, 2005, Rapid, high-yield expression and purification of Ca2+-ATPase regulatory proteins for high-resolution structural studies, Protein Expr. Purif., 40, 118, 10.1016/j.pep.2004.11.015 · doi:10.1016/j.pep.2004.11.015
- Trieber, 2005, The effects of mutation on the regulatory properties of phospholamban in co-reconstituted membranes, Biochemistry, 44, 3289, 10.1021/bi047878d · doi:10.1021/bi047878d
- Eletr, 1972, Phospholipid orientation in sarcoplasmic reticulum membranes. Spin-label ESR and proton NMR studies, Biochim. Biophys. Acta, 282, 174, 10.1016/0005-2736(72)90321-5 · DOI · Paper page
- Stokes, 1990, Three-dimensional crystals of Ca-ATPase from sarcoplasmic reticulum. Symmetry and molecular packing, Biophys. J., 57, 1, 10.1016/S0006-3495(90)82501-7 · DOI
- Young, 2001, Locating phospholamban in co-crystals with Ca2+-ATPase by cryoelectron microscopy, Biophys. J., 81, 884, 10.1016/S0006-3495(01)75748-7 · DOI
- Reddy, 1996, Purified, reconstituted cardiac Ca2+-ATPase is regulated by phospholamban but not by direct phosphorylation with Ca2+/calmodulin-dependent protein kinase, J. Biol. Chem., 271, 14964, 10.1074/jbc.271.25.14964 · DOI
- Ferrington, 2002, Comparable levels of Ca-ATPase inhibition by phospholamban in slow-twitch skeletal and cardiac sarcoplasmic reticulum, Biochemistry, 41, 13289, 10.1021/bi026407t · DOI
- Negash, 1996, Phosphorylation of phospholamban by cAMP-dependent protein Kinase enhances interactions between Ca-ATPase polypeptide chains in cardiac sarcoplasmic reticulum membranes, Biochemistry, 35, 11247, 10.1021/bi960864q · DOI
- Warren, 1974, Reconstitution of a calcium pump using defined membrane components, Proc. Natl. Acad. Sci. U.S.A., 71, 622, 10.1073/pnas.71.3.622 · DOI · Paper page
- Inesi, 1988, Kinetic and equilibrium characterization of an energy-transducing enzyme and its partial reactions, Methods Enzymol., 157, 154, 10.1016/0076-6879(88)57074-X · doi:10.1016/0076-6879(88)57074-x
- Cantilina, 1993, Comparative studies of cardiac and skeletal sarcoplasmic reticulum ATPases. Effect of phospholamban antibody on enzyme activation, J. Biol. Chem., 268, 17018, 10.1016/S0021-9258(19)85295-X · DOI · Paper page
- Trieber, 2009, Effects of phospholamban transmembrane mutants on the calcium affinity, maximal activity, and cooperativity of the sarcoplasmic reticulum calcium pump, Biochemistry, 48, 9287, 10.1021/bi900852m · DOI
- Toyofuku, 1994, Amino acids Glu-2 to Ile-18 in the cytoplasmic domain of phospholamban are essential for functional association with the Ca-ATPase of sarcoplasmic reticulum, J. Biol. Chem., 269, 3088, 10.1016/S0021-9258(17)42051-5 · DOI · Paper page
- Hou, 2010, Relative affinity of calcium pump isoforms for phospholamban quantified by fluorescence resonance energy transfer, J. Mol. Biol., 402, 210, 10.1016/j.jmb.2010.07.023 · doi:10.1016/j.jmb.2010.07.023
- Reddy, 1999, Co-reconstitution of phospholamban mutants with the Ca-ATPase reveals dependence of inhibitory function on phospholamban structure, J. Biol. Chem., 274, 7649, 10.1074/jbc.274.12.7649 · doi:10.1074/jbc.274.12.7649
- Toyoshima, 2003, Modeling of the inhibitory interaction of phospholamban with the Ca2+ ATPase, Proc. Natl. Acad. Sci. U.S.A., 100, 467, 10.1073/pnas.0237326100 · DOI · Paper page
- Stokes, 2006, Interactions between Ca2+-ATPase and the pentameric form of phospholamban in two-dimensional co-crystals, Biophys. J., 90, 4213, 10.1529/biophysj.105.079640 · doi:10.1529/biophysj.105.079640
- Gustavsson, 2011, Activating and deactivating roles of lipid bilayers on the Ca2+-ATPase/phospholamban complex, Biochemistry, 50, 10367, 10.1021/bi200759y · DOI
- Glaves, 2011, Phosphorylation and mutation of phospholamban alter physical interactions with the sarcoplasmic reticulum calcium pump, J. Mol. Biol., 405, 707, 10.1016/j.jmb.2010.11.014 · DOI
- Reddy, 1995, Functional reconstitution of recombinant phospholamban with rabbit skeletal Ca-ATPase, J. Biol. Chem., 270, 9390, 10.1074/jbc.270.16.9390 · doi:10.1074/jbc.270.16.9390
- Louis, 1987, Phospholamban stoichiometry in canine cardiac muscle sarcoplasmic reticulum, Neurochem. Res., 12, 937, 10.1007/BF00966316 · doi:10.1007/bf00966316
- Colyer, 1991, Dependence of cardiac sarcoplasmic reticulum calcium pump activity on the phosphorylation status of phospholamban, J. Biol. Chem., 266, 17486, 10.1016/S0021-9258(19)47398-5 · DOI
- Brittsan, 2000, Maximal inhibition of SERCA2 Ca2+ affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholamban, J. Biol. Chem., 275, 12129, 10.1074/jbc.275.16.12129 · DOI
- Mishra, 2002, Molecular mechanisms of reduced sarcoplasmic reticulum Ca2+ uptake in human failing left ventricular myocardium, J. Heart Lung Transplant., 21, 366, 10.1016/S1053-2498(01)00390-4 · DOI
- Negash, 2000, Phospholamban remains associated with the Ca2+- and Mg2+-dependent ATPase following phosphorylation by cAMP-dependent protein kinase, Biochem. J., 351, 195, 10.1042/bj3510195 · doi:10.1042/bj3510195
- Karim, 2006, Phosphorylation-dependent conformational switch in spin-labeled phospholamban bound to SERCA, J. Mol. Biol., 358, 1032, 10.1016/j.jmb.2006.02.051 · DOI
- Traaseth, 2006, Effects of Ser-16 phosphorylation on the allosteric transitions of phospholamban/Ca2+-ATPase complex, J. Mol. Biol., 358, 1041, 10.1016/j.jmb.2006.02.047 · doi:10.1016/j.jmb.2006.02.047
- Kimura, 1997, Phospholamban inhibitory function is enhanced by depolymerization, J. Biol. Chem., 272, 15061, 10.1074/jbc.272.24.15061 · DOI · Paper page
- Grünig, 1998, Frequency and phenotypes of familial dilated cardiomyopathy, J. Am. Coll. Cardiol., 31, 186, 10.1016/S0735-1097(97)00434-8 · DOI · Paper page
- Chen, 2010, Ca2+ binding to site I of the cardiac Ca2+ pump is sufficient to dissociate phospholamban, J. Biol. Chem., 285, 3253, 10.1074/jbc.M109.080820 · doi:10.1074/jbc.m109.080820
- Akin, 2012, Characterizing phospholamban to SERCA2a binding interactions in human cardiac sarcoplasmic reticulum vesicles using chemical cross-linking, J. Biol. Chem., 287, 7582, 10.1074/jbc.M111.334987 · doi:10.1074/jbc.m111.334987
- James, 1989, Nature and site of phospholamban regulation of the Ca2+ pump of sarcoplasmic reticulum, Nature, 342, 90, 10.1038/342090a0 · DOI · Paper page
- Chen, 2007, Mechanism of reversal of phospholamban inhibition of the cardiac Ca2+-ATPase by protein kinase A and by anti-phospholamban monoclonal antibody 2D12, J. Biol. Chem., 282, 20968, 10.1074/jbc.M703516200 · doi:10.1074/jbc.m703516200
- Fowler, 1989, The effects of calcium, temperature, and phospholamban phosphorylation on the dynamics of the calcium-stimulated ATPase of canine cardiac sarcoplasmic reticulum, Biochim. Biophys. Acta, 980, 348, 10.1016/0005-2736(89)90323-4 · doi:10.1016/0005-2736(89)90323-4
- Bidwell, 2011, Phospholamban binds with differential affinity to calcium pump conformers, J. Biol. Chem., 286, 35044, 10.1074/jbc.M111.266759 · DOI · Paper page
- Lockamy, 2011, Functional and physical competition between phospholamban and its mutants provides insight into the molecular mechanism of gene therapy for heart failure, Biochem. Biophys. Res. Commun., 408, 388, 10.1016/j.bbrc.2011.04.023 · DOI
- Chen, 2005, Role of leucine 31 of phospholamban in structural and functional interactions with the Ca2+ pump of cardiac sarcoplasmic reticulum, J. Biol. Chem., 280, 10530, 10.1074/jbc.M414007200 · DOI
- Liu, 1998, Guidelines for membrane protein engineering derived from de novo designed model peptides, Biopolymers, 47, 41, 10.1002/(SICI)1097-0282(1998)47:1<41::AID-BIP6>3.0.CO;2-X · DOI
Cited by
Gorski, P. A., Ceholski, D. K., & Hajjar, R. J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.01.005 · Cited by 213
Self-citationWeber, D. K., Reddy, U. V., Robia, S. L., & Veglia, G. (2024) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2024.184370 · Cited by 8
Metadata
- Authors
- Ceholski, D. K., Trieber, C. A., & Young, H. S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2012-05
- Volume
- 287
- Issue
- 20
- Pages
- 16521-16529
- ISSN
- 0021-9258
- Cited by
- 63
- References
- 1
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 3058 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hydrophobic Imbalance in the Cytoplasmic Domain of Phospholamban Is a Determinant for Lethal Dilated Cardiomyopathy. https://app.cochat.ai/papers/10.1074/jbc.m112.360859
- The paper
- Ceholski, D. K., Trieber, C. A., & Young, H. S. (2012). Hydrophobic Imbalance in the Cytoplasmic Domain of Phospholamban Is a Determinant for Lethal Dilated Cardiomyopathy. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.m112.360859
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.